Zota Health Care appoints Akshay Kumar as brand ambassador

2 min read     Updated on 20 May 2026, 02:16 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Zota Health Care Limited has appointed actor Akshay Kumar as brand ambassador for the company and UGO Generic, a B2B and B2C brand under its subsidiary KMHP Ventures. The initiative aims to distribute generic medicines through owned stores and 12.5 lakh retail pharmacies, enhancing national presence.

powered bylight_fuzz_icon
40769168

*this image is generated using AI for illustrative purposes only.

zota healthcare has appointed Mr. Akshay Kumar as the brand ambassador for the company and its UGO Generic brand. The legendary actor and fitness icon will represent the company and the brand operated by M/s KMHP Ventures Limited, a Wholly Owned Subsidiary of Zota Health Care Limited. This strategic move is aimed at catalyzing brand expansion and strengthening the company's national presence.

UGO Generic is designed as a B2B and B2C brand that will offer high-quality generic medicines on a PAN India basis. The distribution strategy includes selling through owned stores as well as approximately 12.5 lakh retail pharmacies that are planned to be onboarded under the UGO Generic network. The company believes that Mr. Kumar's association will add significant strength and mass connect as it advances its vision of making affordable, high-quality generic medicines accessible across the country.

Strategic Alignment and Vision

The collaboration is viewed as a defining milestone for Zota Health Care Limited as it seeks to deepen consumer trust. The company highlighted that Mr. Kumar's reputation for discipline, resilience, and enduring excellence aligns with the core values of Zota and UGO Generic—trust, reach, and a mission to make quality healthcare available to every home in India.

Mr. Ketankumar Zota, Chairman of Zota Health Care Limited, commented on the development, stating that the company is delighted to welcome Mr. Akshay Kumar to the Zota family. He noted that Mr. Kumar's influence extends beyond cinema and that his qualities of discipline, reliability, and integrity align closely with the company's mission of making healthcare affordable and accessible.

Company Overview

Zota Health Care Ltd., listed on the NSE, has been operating in the Indian healthcare industry since 2000. Headquartered in Surat, the company employs over 520 professionals and specializes in the development, manufacturing, and marketing of pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. The company operates through three main divisions: marketing, export, and the retail pharmacy chain.

Division Description
Marketing Development and marketing of healthcare products
Export International trade operations
Retail Pharmacy Chain Management of generic pharmacy outlets

In 2017, the company launched Davaindia, a generic pharmacy chain offering over 2,000 SKUs of quality medicines. This strategic business model utilizes backward and forward integration to manage the entire product life cycle efficiently. The company continues to invest in its Research and Development team to pioneer healthcare solutions.

Historical Stock Returns for Zota Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.14%+1.85%-6.00%-27.15%+23.45%+713.85%

How will Zota Health Care's UGO Generic brand differentiate itself from existing generic pharmacy chains like Davaindia, and could this lead to internal competition within the company's own retail network?

What is the realistic timeline and capital requirement for onboarding 12.5 lakh retail pharmacies under the UGO Generic network, and how might this aggressive expansion impact the company's financials?

Could Akshay Kumar's brand ambassadorship trigger similar celebrity-driven marketing moves by competing generic medicine players like Jan Aushadhi or other pharma retail chains?

Zota Healthcare to host Q4FY26 earnings call on May 25

1 min read     Updated on 20 May 2026, 01:51 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Zota Health Care Limited will announce its Q4 and FY26 financial results on May 22, 2026, followed by an earnings conference call on May 25, 2026, at 15:30 hrs IST. The 60-minute call will feature senior management, including the Founder, Managing Director, and Group CEO. Investors can access the call via specific dial-in numbers or through a pre-registration process.

powered bylight_fuzz_icon
40767702

*this image is generated using AI for illustrative purposes only.

Zota Health Care Limited has announced that it will host an earnings conference call to discuss its financial performance for the fourth quarter and fiscal year ended March 31, 2026. The company is scheduled to release its Q4FY26 results on May 22, 2026. Following this announcement, the management will engage with investors and analysts to provide insights into the financial outcomes.

Earnings Call Schedule

The conference call is set to take place on Monday, May 25, 2026. The session will allow stakeholders to hear directly from the company's leadership regarding the quarterly and annual results. The management team will detail the financial figures and operational highlights during the interaction.

Call Details

Participants are encouraged to join the call to understand the company's performance and future outlook. The specific logistics for the conference call are outlined below:

Parameter Details
Date Monday, May 25, 2026
Time 15:30 hrs. IST
Duration 60 minutes
Universal Dial-in Numbers +91 22 6280 1107 / +91 22 7115 8008

The company has advised participants to dial in 10 minutes prior to the start time to avoid any delays. Additionally, a pre-registration facility is available for those who wish to receive direct call details via email.

Management Representation

The earnings call will feature key members of the Zota Health Care Limited leadership team. The speakers will include Mr. Himanshu Zota, Founder and Whole Time Director; Mr. Moxesh Zota, Managing Director; and Dr. Sujit Paul, Group Chief Executive Officer. They will address queries and provide strategic guidance during the session.

Historical Stock Returns for Zota Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.14%+1.85%-6.00%-27.15%+23.45%+713.85%

How might Zota Health Care's Q4FY26 revenue growth compare to its peers in the mid-cap pharmaceutical sector, and what does this signal about its competitive positioning?

Given the presence of both the Founder and Managing Director on the earnings call, what strategic initiatives or potential mergers and acquisitions could management hint at for FY27?

How could Zota Health Care's export market performance in Q4FY26 reflect broader trends in India's pharmaceutical export landscape amid global supply chain shifts?

More News on Zota Healthcare

1 Year Returns:+23.45%